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The denaturation of transferrin by urea has been studied by (a) electrophoresis in
polyacrylamide gels incorporating a urea gradient, (b) measurements of the loss in
iron-binding capacity and (c) u.v. difference spectrometry. In human serum transferrin
and hen ovotransferrin the N-terminal and C-terminal domains of the iron-free protein
were found to denature at different urea concentrations.
Makey & Seal (1976) showed that partially
iron-saturated human transferrin can be resolved
into four bands by polyacrylamide-gel electro-
phoresis in a buffer containing 6 M-urea. The slowest
and fastest components represent the apoprotein and
the diferric form of the protein respectively, and the
two intermediate components represent the two
monoferric forms of the protein. The identification of
the two intermediate components was achieved by
Evans & Williams (1978). Partial saturation of
human serum transferrin with iron(III) nitrilotri-
acetate was found to give rise to the slower
intermediate component, and proteolytic digestion of
this substance produced an iron-containing fragment
of mol.wt. 43000 that contained carbohydrate. On
the other hand, partial saturation with other iron
donors, including FeCl3, gave rise to the faster
intermediate component, and on proteolytic
digestion this substance yielded an iron-containing
fragment of mol.wt. 36000 that was devoid of
carbohydrate. Since the amino-acid-sequence
determinations of MacGillivray et al. (1977) had
shown that carbohydrate is present only in the
C-terminal half of the polypeptide chain, Evans &
Williams (1978) inferred that the slower inter-
mediate component represents the monoferric trans-
ferrin with iron in the C-terminal binding site (TfFe)
and that the faster intermediate band represents the
N-terminal monoferric transferrin (FeTf). Partially
iron-saturated hen ovotransferrin also gives four
bands upon polyacrylamide-gel electrophoresis in
urea-containing buffers, and from similar evidence
these can be identified as corresponding to the
iron-free protein, the C-terminal monoferric trans-
ferrin (OTFe), the N-terminal monoferric trans-
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ferrin (FeOT) and the diferric transferrin in the order
of increasing electrophoretic mobility (Williams et
al., 1978).
This method of electrophoresis has proved useful
in determining the distribution of iron between the
two binding sites of human transferrin (Evans &
Williams, 1978; Aisen et al., 1978; Leibman &
Aisen, 1979; Williams & Moreton, 1980) and of hen
ovotransferrin (Williams et al., 1978), since Aisen et
al. (1978) have shown that no rearrangement of
bound iron occurs during electrophoresis.
Electrophoretic separations of transferrins bear-
ing different numbers of iron atoms in non-denatur-
ing buffer solutions can be obtained as a result of the
increased numbers of negative charges on molecules
carrying iron (Aisen et al., 1966). The separation of
the different forms of transferrin in urea-containing
buffers is likely to depend on two further effects. The
first is the increased stability of iron-protein com-
plexes to urea denaturation (Azari & Feeney, 1958).
Secondly, as Makey & Seal (1976) suggested, the
magnitudes of the decreases in electrophoretic
mobility caused by the unfolding of the two domains
of the protein may not be equal. Although there have
been many quantitative studies of the denaturation
of transferrin by urea (e.g. Glazer & McKenzie,
1963; Yeh et al., 1979), there appears to be no
information about possible differences between the
N-terminal and C-terminal domains.
Creighton (1979) showed that the denaturation of
proteins by urea can be studied by electrophoresis of
a band of protein through a slab of gel in which there
is a gradient of urea concentration perpendicular to
the direction of electrophoresis. With several pro-
teins, curves were obtained that were consistent with
a rapidly reversible denaturation process in which
only the native protein and the fully unfolded protein
were detectable.
In the present paper we describe the application of
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urea-gradient/polyacrylamide-gel electrophoresis to
several transferrins and show that the unfolding of
the two domains occurs in two distinct steps.
Materials and methods
Transferrins
Human serum transferrin was isolated from Cohn
IV fraction as described previously (Evans &
Williams, 1978). Hen and duck ovotransferrins were
isolated from the egg whites as described by
Williams (1968). Pig transferrin and horse trans-
ferrin were isolated by the method of Graham &
Williams (1975). Rat and rabbit transferrin samples
were gifts from Mr. S. Heaphy of this department.
Bovine transferrin was a gift from Dr. J. Brock,
Department of Bacteriology, University of Glasgow,
Glasgow, Scotland, U.K. The removal of iron from
transferrin was carried out as described by Evans &
Williams (1978).
Samples of human serum and orang-utan (Pongo
pygmaeus) serum (the latter kindly supplied by Dr.
C. Pearson, Department of Veterinary Medicine,
University of Bristol, Langford, Bristol, U.K.) were
also examined by the urea/polyacrylamide-gel
electrophoresis after treatment with rivanol to
remove the bulk of the serum proteins (Evans &
Williams, 1978).
Polyacrylamide-gel electrophoresis
Electrophoresis in 6M-urea was carried out as
described by Williams et al. (1978). Urea-gradient/
polyacrylamide gels were prepared essentially as
described by Creighton (1979). In both cases gels
were 1.5mm thick. A linear gradient from 0 to
6 M-urea was produced by using a multichannel
peristaltic pump. Creighton (1979) used a shallow
gradient of acrylamide concentration in the opposite
direction to the urea gradient in order to compen-
sate for a retardation in electrophoretic mobility due
to the urea but not associated with unfolding of the
protein. This step was not used in our experiments
where the acrylamide and NN'-methylenebisacryl-
amide concentrations were kept constant at 6.5%
(w/v) and 0.172% (w/v) respectively.
Protein samples were dissolved in reservoir buffer
containing 0.01% Bromophenol Blue and 10% (w/v)
glycerol to give a protein concentration of 1 mg/ml.
The sample was applied to the top of the gel at
10pl/cm of gel. When serum samples were used,
0.1 ml of serum was mixed with 0.8ml of reservoir
buffer containing 0.375% (w/v) rivanol and 10%
(w/v) glycerol. After centrifugation the supernatant
solution was applied to the gel at 50,ul/cm of gel.
Electrophoresis was carried out for 17h at 1OOV,
and gels were stained with Coomassie Blue R250.
Addition of iron to transferrin in the presence of
urea
The denaturation of iron-free transferrin by urea
was monitored by testing the ability of the protein to
form a complex with iron(III) nitrilotriacetate in the
presence of different concentrations of urea. The
formation of complexes was detected by the A470 and
by electrophoresis in polyacrylamide gels contain-
ing 6 M-urea.
Iron-free hen ovotransferrin or human transferrin
Were dissolved in 0.05 M-NaHCO3 containing differ-
ent concentrations of freshly deionized urea. The
protein concentration was between 3 and 10mg/ml
in different experiments. A calculated amount of
iron(III) nitrilotriacetate to give 100% saturation was
added. Samples were left overnight at 200C before
measuring A470 and performing polyacrylamide-gel
electrophoresis.
U.v. spectra
The denaturation of iron-free transferrin by urea
was also monitored by u.v. difference spectroscopy.
The protein was dissolved in the electrophoresis
reservoir buffer (Tris/EDTA/boric acid, pH 8.4) at a
concentration of 0.4 mg/ml, and a stock solution of
deionized 8M-urea was added to give the desired
urea concentration. The difference spectrum
obtained between the protein in the urea-containing
buffer and the protein in the absence of urea was
similar to that found by Glazer & McKenzie (1963).
Spectra were recorded on a Pye-Unicam SP. 8-100
instrument. The height of the difference peak at
292nm was used as a measure of protein unfolding.
Results
Electrophoresis of human transferrin in urea-
gradient/polyacrylamide gels
Fig. 1 shows that increasing urea concentration
from 0 to 6 M decreases the electrophoretic mobility
of iron-free transferrin to about 43% of its original
value in two distinct steps. The first step occurred
over a wider range of urea concentrations (approx.
2.8-4.0M) than the second (approx. 4.1-4.5M), but
approximately equal amounts of retardation
occurred in each step. Thus at 4.0 M-urea the
mobility is 70% of the value at 2.8M-urea and at
4.5 M-urea it is 65% of the value at 4.0 M-urea.
Fig. 2 shows the pattern given by a partially
iron-saturated sample of human transferrin in which
all four forms of the protein were present. The
diferric form showed no denaturation steps over the
range of urea concentration used. The monoferric
complex, in which the single iron atom occupies the
N-terminal binding site (FeTf), showed a single
denaturation step that coincided with the first of the
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Fig. 1. Electrophoresis of iron-free human transferrin
and hen ovotransferrin in a urea-gradient/polyacryl-
amide gel
A mixture of the two proteins was electrophoresed in
the same gel. (a) Human transferrin; (b) hen
ovotransferrin.
Fig. 3. Electrophoresis ofa fresh sample ofhuman serum
after treatment with rivanol on a urea-gradient/poly-
acrylamide gel
The transferrin bands are labelled as in Fig. 2.
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Fig. 2. Electrophoresis ofpartially iron-saturated human
transferrin on a urea-gradient!polyacrylamide gel
A partially iron-saturated sample of human trans-
ferrin containing all four forms of the protein was
applied to the gel. It was prepared by adding small
amounts of iron, as Fe(II)S04 and iron(III) nitrilo-
triacetate, to apotransferrini (Evans & Williams,
1978). The diferric protein is labelled 'Fe2Tf', the
N-terminal monoferric complex 'FeTf', the C-
terminal monoferric complex 'TfFe' and the apo-
protein 'Tf'.
two denaturation steps for iron-free transferrin
(approx. urea concentration at the midpoint of the
step, 3.4M). This suggests that this step represents
the denaturation of the iron-free C-terminal domain
of the protein. The monoferric complex with an iron
atom bound to the C-terminal site (TfFe) also
showed a single denaturation step at a slightly higher
urea concentration than the second of the two
denaturation steps for the iron-free protein (approx.
urea concentration at the mid-point of the step,
4.8M, as compared with 4.3M). The unfolding of
TfFe complex decreased its electrophoretic mobility
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to about 59% of its value at urea concentrations
below 4.2M, causing the TfFe complex to migrate
more slowly than the FeTf complex. Again it can be
seen that the unfolding of the N-terminal domain
occurs over a narrower range of urea concentration
than the unfolding of the C-terminal domain.
When fresh human serum was treated with rivanol
and subjected to urea-gradient electrophoresis, the
pattern obtained was essentially the same as that
given by purified transferrin (Fig. 3). The con-
centration of the N-terminal monoferric form is
greater than that of the C-terminal monoferric form,
as Leibman & Aisen (1979) and Williams &
Moreton (1980) have shown recently.
Electrophoresis of hen ovotransferrin in urea-
gradient/polyacrylamide gels
Fig. 1 shows that, in a urea-gradient/polyacryl-
amide gel, the electrophoretic mobility of iron-free
ovotransferrin is decreased to about. 39% of its value
at low urea concentrations. This decrease appears to
take place as a single step that occurs at the same
urea concentration as the first step of iron-free
human transferrin (approx. 3.4 M), although the
slope of the line is steeper in the case of the hen
protein.
A partially iron-saturated sample in which all four
protein components were present gave the pattern
shown in Fig. 4. The diferric protein showed no
marked change in electrophoretic behaviour. The
C-terminal monoferric complex (OTFe) showed a
single-step decrease in mobility to 50% of its original
value. This step occurred at the same urea con-
centration as did the retardation of the iron-free
protein. The N-terminal monoferric complex (FeOT)
showed a much smaller decrease in mobility, to 68%
of its original value, and this took place at a higher
urea concentration (approx. 3.8 M) than did the
unfolding of the iron-free protein.
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Fig. 4. Electrophoresis of partially iron-saturated hen
ovotransferrin on a urea-gradient! polyacrylamide gel
The diferric protein is labelled 'Fe2OT', the N-
terminal monoferric complex 'FeOT', the C-terminal
monoferric complex 'OTFe' and the apoprotein
'OT'. This mixture was prepared by adding a small
amount of iron(III) nitrilotriacetate to ovotransferrin
as prepared by the method of Williams (1968).
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Fig. 6. Iron-binding capacity of hen ovotransferrin in
urea solutions
Saturating amounts of iron were added to solutions
of the iron-free protein (2.9 mg/ml) containing
different concentrations of urea. For conditions, see
the text.
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Fig. 5. Iron-binding cap
mobility to 32-49% of the original value. Rivanol-
treated samples of serum from the orang-utan, on
3 4 5 6 7 8 the other hand, gave a pattern similar to that of
lUreal (M) human serum, in which the decrease in mobility of
,acity of human transferrin in iron-free transferrin showed two distinct steps.-
-co. -~ - ~-~~~-o- - _ _ C s r -v-
urea solutions
Saturating amounts of iron were added to solutions
of the iron-free protein (2.9 mg/ml) containing
different concentrations of urea. For conditions, see
the text.
Electrophoresis ofother transferrins
On electrophoresis in urea-gradient/poly-
acrylamide gels the iron-free transferrins of rat,
rabbit, pig, horse and cow, and duck ovotransferrin,
all showed an apparently single-step decrease in
Ability of transferrin to bind iron in the presence of
urea
When a saturating dose of iron(III) nitrilotri-
acetate was added to iron-free human transferrin in
the presence of different concentrations of urea, the
ability of the protein to form a coloured complex
was destroyed in the concentration range 5.0-7.2M
(Fig. 5).
Polyacrylamide-gel electrophoresis in 6 M-urea
showed that from 5.2 to 6.8M-urea the N-terminal
monoferric complex (FeTf) was present as an
intermediate component. There was no sign of the
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Fig. 7. Electrophoresis ofovotransferrin after addition ofiron to the protein in different urea concentrations
A saturating dose of iron was added to ovotransferrin dissolved in urea solution. Electrophoresis in a polyacrylamide
gel containing 6 M-urea was carried out 3 h later. 'M' denotes a marker sample containing apoprotein (OT), the
C-terminal monoferric complex (OTFe) and the diferic protein (Fe2Tf). (a) Urea concentrations 0.8-5.OM; (b) urea
concentrations 5.2-7.6 M.
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Fig. 8. U.v. difference peak of iron-free transferrin in
urea solutions
Difference spectra of transferrin in urea solutions
against transferrin in urea-free solutions were
measured. The protein concentration was 0.4 mg/mi.
(a) Hen ovotransferrin; (b) human transferrin.
C-terminal monoferric complex (TfFe). This showed
that the iron-binding capacity of the C-terminal
domain of human transferrin is lost before that of the
N-terminal domain. Hen ovotransferrin lost its
ability to bind iron in the range 4.0-6.0M-urea (Fig.
6), and electrophoresis showed that, over this range,
the C-terminal monoferric complex (OTFe) was
present as the sole intermediate (Fig. 7). Therefore in
this protein, despite an apparently single-step
denaturation process (as judged by urea-gradient/
polyacrylamide-gel electrophoresis and by the loss of
iron-binding capacity), the N-terminal domain is
denatured before the C-terminal domain.
U.v. diference spectroscopy
Fig. 8 shows that, for both iron-free human
transferrin and iron-free hen ovotransferrin, in-
crease in the height of the 292nm difference peak
occurs over a wide range of urea concentrations:
aprox. 3.0-7.OM for human transferrin and 3.5-
6.5 M for ovotransferrin.
Discussion
In these experiments the urea denaturation of
iron-free transferrin has been studied by u.v.
measurements, gel electrophoresis and iron-binding
measurements. The main finding is that these three
methods reveal different aspects of the denaturation
of transferrin. U.v. measurements show that un-
folding of the protein occurs over a wide range of
urea concentrations (3-7M-urea for human trans-
ferrin and 3.5-6.5M-urea for ovotransferrin). The
decrease in electrophoretic mobility takes place in
the lower part of this range of urea concentrations.
In human transferrin, two distinct steps occurred at
2.8-4.0M-urea and 4.1-4.5 M-urea. From the
behaviour of the monoferric complexes (see below) it
is suggested that the first step is due to the unfolding
of the C-terminal domain and the second step to that
of the N-terminal domain. In ovotransferrin a
single-step decrease in mobility was seen, with its
mid-point at 3.4 M-urea, and this probably re-
presents the simultaneous unfolding of both do-
mains. The loss of ability to bind iron, as judged by
A470, takes place in the upper part of the urea
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concentration range (5-7.2 M-urea for human trans-
ferrin and 4-6 M-urea for ovotransferrin). Thus
iron-binding can still occur in a concentration of
urea causing maximum decrease in electrophoretic
mobility. Moreover, there is sequential loss of
iron-binding ability by the two domains in both
human transferrin and ovotransferrin (Fig. 7),
despite the fact that, in the latter protein, the two
domains appear to denature simultaneously, as
judged by electrophoresis. In human transferrin the
C-terminal domain loses its iron-binding ability
before the N-terminal domain does. In ovotrans-
ferrin the order is reversed.
In the denaturation of the monoferric transferrin
complexes the unfolding of the iron-free domain is
assumed to be responsible for the decrease in
electrophoretic mobility, since the diferric protein
complexes appear completely to resist unfolding as
judged by this method. Fig. 2 shows that FeTf
denatures at the same urea concentration as the first
step for iron-free Tf. It is likely, therefore, that in
both cases this step is due to the unfolding of the
C-terminal domain. There is also evidence (Figs. 2
and 4) that, for some monoferric complexes, the
iron-free domain received some protection against
urea denaturation from the presence of an iron atom
in the other domain. Thus, for human transferrin, the
N-terminal domain in the monoferric complex TfFe
unfolds at a higher urea concentration than does the
N-terminal domain in the iron-free protein. In
ovotransferrin the C-terminal domain is more stable
in the monoferric complex FeOT than in the
iron-free protein. On the other hand, there appears to
be no protection of the C-terminal domain in FeTf or
of the N-terminal domain in OTFe. The chemical
basis for this asymmetrical effect is completely
unknown. The resolution of the two monoferric
complexes during electrophoresis in 6M-urea/poly-
acrylamide gels depends on the fact that, in both
human transferrin and hen ovotransferrin, the
unfolding of the N-terminal domain causes a greater
decrease in mobility than does the unfolding of the
C-terminal domain.
Structural differences that might explain the
different stabilities of the two domains towards the
effects of urea are unknown. Disulphide bridges are
thought to be important in maintaining stability, but
in ovotransferrin the half-cystine contents of the N-
and C-terminal domains are approximately equal
(Williams, 1975), whereas, in human transferrin,
MacGillivray et al. (1977) found sixteen half-cystine
residues in the C-terminal half of the polypeptide
chain and only eight in the N-terminal half.
However, Evans & Williams (1978) found nearly
equal half-cystine contents for the N-terminal and
C-terminal fragments ofhuman transferrin.
Differential calorimetry has been used to obtain
information on the thermal denaturation of trans-
ferrin. Donovan & Ross (1976) found that iron-free
human transferrin showed two peaks of thermal
denaturation, at 62 and 720C, and suggested that
these represented the denaturation of the two
domains of the protein. It is not known which
domain corresponds to each peak of thermal
denaturation. On the other hand, iron-free hen
ovotransferrin gave a single peak of denaturation at
630C (Donovan & Ross, 1975). These results are
similar to those on urea denaturation reported here.
Evans et al. (1977) studied the thermal denatur-
ation of the N-terminal and C-terminal iron-binding
fragments obtained from ovotransferrin by partial
proteolysis. They found that the N-terminal frag-
ment denatured at 56.5 °C and the C-terminal
fragment at 600C. Although data on fragments
cannot be compared directly with data on the whole
protein, the calorimetry is consistent with the finding
that the N-terminal domain of the ovotransferrin
denatures before the C-terminal in urea solutions.
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